Zhuhai Qianlie Pharmaceutical Co., Ltd. announced that it has raised not more than CNY 25 million in an equity round of funding on October 16, 2023. The transaction involved participation from new investor Hunan Warrant Pharmaceutical Co.,Ltd. invest no more than CNY 22 million and Zhuhai Qianlie Pharmaceutical Co., Ltd. for invest no more than CNY 3 million. This transaction has been reviewed and approved at the sixth extraordinary meeting of the company's third board of directors and the sixth extraordinary meeting of the third board of supervisors of Hunan Warrant Pharmaceutical Co.,Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.88 CNY | +4.46% | -0.21% | -12.38% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.38% | 555M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- 688799 Stock
- News Hunan Warrant Pharmaceutical Co.,Ltd
- Zhuhai Qianlie Pharmaceutical Co., Ltd. announced that it expects to receive CNY 25 million in funding from Hunan Warrant Pharmaceutical Co.,Ltd